AbbVie reconsiders Shire deal over tax laws
October 15, 2014Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax
AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …
BT and Exostar partner on research software
October 15, 2014Medical Communications, Research and Development, Sales and Marketing BT, cloud, exostar, iam, life sciences, software, workbench
Cloud computing company Exostar has become a partner of BT for Life Sciences, allowing its Identity and Access Management (IAM) …
Telescope implant for macular degeneration approved
October 15, 2014Medical Communications, Sales and Marketing FDA, VisionCare Ophthalmic Technologies, macular degeneration, telescope implant
Medical device development firm VisionCare Ophthalmic Technologies has had its implantable miniature telescope for age-related macular degeneration disease approved by …
FDA approves Eisai’s chemo side-effects drug
October 15, 2014Research and Development, Sales and Marketing Eisai, FDA, Helsinn, akynzeo, chemotherapy, cinv
Eisai and Helsinn Healthcare’s Akynzeo (netupitant/palonosetron) has received FDA approval for the treatment of chemotherapy-induced nausea and vomiting (CINV). CINV …
Scottish Lifesciences Association welcomes chair
October 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ken Sutherland, Scottish Lifesciences Association
The Scottish Lifesciences Association has named Dr Ken Sutherland as its new chair. Sutherland joins from Toshiba Medical Visualisation Systems …
Have you been tempted to translate online?
October 14, 2014The need to communicate across the world is growing every day and with it the demand for translation services, particularly …
BMS, Pharmacyclics and Janssen collaborate on cancer
October 14, 2014Research and Development, Sales and Marketing BMS, Janssen, Pharmacyclics, imbruvica, opdivo
Bristol-Myers Squibb, Pharmacyclics and Janssen are to collaborate on clinical trials combining BMS’s cancer drug Opdivo (nivolumab) with Janssen and …
Chinese military-linked firm says it has Ebola cure
October 14, 2014Medical Communications, Sales and Marketing Ebola, WHO, amms, brincidofovir, sihuan pharmaceutical holdings, tekmira, zmapp
A Chinese drugmaker that has close military ties is seeking fast-track approval for its JK-05 drug that it says can …
NICE releases ‘person-centred’ medicines optimisation guidelines
October 14, 2014Research and Development, Sales and Marketing ABPI, NHS, NICE, UK, WHO, Whitehead
NICE has recently released the draft of its first guidance on medicines optimisation that it hopes will be more person-centered …
Pfizer breast cancer pill gets FDA nod
October 14, 2014Research and Development, Sales and Marketing FDA, Femera, LEE011, Pfizer, bemaciclib, breast cancer, palbociclib
Pfizer’s experimental breast cancer drug palbociclib has been accepted and granted a priority review by the US Food and Drug …
Havas Life Medicom recruits from Pan
October 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jon Linscott, Pan, havas life medicom
Healthcare comms firm Havas Life Medicom has appointed Jon Linscott to its team to serve as a senior director. Linscott …
Hospira recalls drug due to storage hiccup
October 13, 2014Manufacturing and Production, Sales and Marketing FDA, Hospira, Vancocin, Vancomycin hydrochloride, lilly
Hospira has issued a recall of one lot of its injectable vancomycin hydrochloride in the US due to ‘uncontrolled storage …
Steris to buy UK’s Synergy Health for $1.9 billion
October 13, 2014Manufacturing and Production, Sales and Marketing health, manufacturing, steris, synergy, tax
US-based medical technology firm Steris Corporation is to purchase Synergy Health in the UK for $1.9 billion and will shift …
EMA keeps Ariad cancer drug on the market
October 13, 2014Sales and Marketing Ariad, CML, EMA, PRAC, iclusig, leukaemia, ponatinib
The EMA has recommended Ariad’s leukaemia drug Iclusig (ponatinib) should continue to be used under its current indication despite ongoing …
NHS staff striking over pay
October 13, 2014Medical Communications, Sales and Marketing British Association of Occupational Therapists., GMB, GPs, Hunt, NHS, UCATT, midwives, strike
Over 400,000 NHS staff have gone on strike for four hours as a 1% pay rise requested by Unions was …
Patricell appoints sales executive
October 13, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carla stemate, patricell
Nottingham-based healthcare products firm Patricell is adding Carla Stemate to its team as a sales executive. Based at BioCity, Stemate …
Pharma and transparency: actions speak louder than words
October 13, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, alltrials, andrew powrie-smith, hcp, transparency
As an industry we continue to deliver innovative, life changing medicines and rewrite the story of many diseases, yet our …
Novartis signs $90m deal with Oxford BioMedica
October 10, 2014Manufacturing and Production, Research and Development, Sales and Marketing CART-019, Novartis, Oxford BioMedica, immunotherapy, oxb
UK-based biotech Oxford BioMedica is working with Novartis in a transformational deal for the firm worth $90 million to develop …
Endo buys Auxilium for $2.6 billion
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Endo, Testim, Testopel, auxilum
Endo International has agreed a $2.6 billion deal to buy Auxilium Pharmaceuticals in order for the company to gain access …
New chief executive for Tonic Life Communications
October 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huntsworth Health, mary smiddy, tonic life communications
Healthcare comms consultancy Tonic Life Communications that is a part of the Huntsworth Health family of agencies, has confirmed the …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
